Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2025-09-04 2025-09-04
Drug Identification Number 02230897 02230897
Brand name BILTRICIDE BILTRICIDE
Common or Proper name PRAZIQUANTEL PRAZIQUANTEL
Company Name BAYER INC BAYER INC
Ingredients PRAZIQUANTEL PRAZIQUANTEL
Strength(s) 600MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6's 6's
ATC code P02BA P02BA
ATC description ANTITREMATODALS ANTITREMATODALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2025-09-04 2025-09-04
Remaining supply date 2027-03-31 2027-03-31
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Health Canada has authorized temporary importation and sale of foreign authorized Biltricide. Supply of foreign authorized Biltricide is expected to be available until March 31, 2027. Health Canada has authorized temporary importation and sale of foreign authorized Biltricide. Supply of foreign authorized Biltricide is expected to be available until March 31, 2027.
Health Canada comments